Aly Azeem Khan

This inventor holds 21 USPTO granted patents and 19 published patent applications and 7 EPO patents, primarily in Cancer Research. Top assignees: Tempus Labs, Inc., Tempus Ai, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aly Azeem Khan. Retrieved from https://idiyas.com/inventor/aly-azeem-khan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 19)

% Patents Active = 100.0

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 117(Granted Patents)

Company Filing History:

Years Active: 2021-2026

Loading Chart...

Areas of Expertise:

Cytotoxic Gene Signature

Biomarkers

Therapeutic Sensitivity

Histopathology

Deep Learning

Machine Learning

Nucleic Acid Yield

Organoid Analysis

Pathogen Detection

Image Training Datasets

TCR/BCR Profiling

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12618115 - Determination of cytotoxic gene signature and associated systems and methods for response prediction and treatment (2026-05-05),

2. 12524826 - Determining biomarkers from histopathology slide images (2026-01-13),

3. 12451250 - Systems and methods for predicting therapeutic sensitivity (2025-10-21),

4. 12165236 - Predicting total nucleic acid yield and dissection boundaries for histology slides (2024-12-10),

5. 12129519 - TCR/BCR profiling using enrichment with pools of capture probes (2024-10-29),

6. 12112839 - Data based cancer research and treatment systems and methods (2024-10-08),

7. 11935152 - Determining biomarkers from histopathology slide images (2024-03-19),

8. 11741365 - Generalizable and interpretable deep learning framework for predicting MSI from histopathology slide images (2023-08-29),

9. 11727674 - Systems and methods for generating histology image training datasets for machine learning models (2023-08-15),

10. 11705226 - Data based cancer research and treatment systems and methods (2023-07-18),

11. 11640859 - Data based cancer research and treatment systems and methods (2023-05-02),

12. 11610307 - Determining biomarkers from histopathology slide images (2023-03-21),

13. 11561178 - Artificial fluorescent image systems and methods (2023-01-24),

14. 11415571 - Large scale organoid analysis (2022-08-16),

15. 11414700 - TCR/BCR profiling using enrichment with pools of capture probes (2022-08-16),

Title: Innovations and Contributions of Inventor Aly Azeem Khan

Introduction: Aly Azeem Khan is an accomplished inventor based in Chicago, IL. With a remarkable portfolio of 18 patents, Khan has made significant contributions to the fields of biotechnology and medical diagnostics. His innovative methods and systems have the potential to transform practices in healthcare and research.

Latest Patents: Among his most recent patents, one focuses on a method for predicting total nucleic acid yield and dissection boundaries for histology slides. This invention allows for a better assessment of tumor cell nucleic acids by qualifying specimens prepared on one or more hematoxylin and eosin (H&E) slides. Another noteworthy patent involves T cell receptor (TCR) and B cell receptor (BCR) profiling. This method utilizes next-generation sequencing (NGS) techniques to create systems for diagnosing and predicting medical conditions based on TCR/BCR profile data.

Career Highlights: Aly Azeem Khan has been involved with notable companies such as Tempus Labs, Inc. and Tempus AI, Inc. Through these roles, he has contributed to advancements in data-driven medical solutions that enhance patient care and treatment strategies.

Collaborations: Throughout his career, Khan has collaborated with skilled professionals, including notable coworkers Stephen Yip and Irvin Ho. Together, they have worked towards achieving innovation in their respective fields, further elevating the impact of their contributions to medical science.

Conclusion: Aly Azeem Khan stands out as a passionate inventor whose work reflects a commitment to advancing healthcare through innovation. His patents and industry collaborations highlight his significant role in developing technologies that have the potential to improve diagnostic and therapeutic methodologies. As he continues to innovate, Khan's influence in biotechnology will likely lead to further advancement in the medical field.

Profile summary based on public USPTO records.